Article
Comparison of three methods for detecting epidermal growth factor receptor mutations in plasma DNA samples of Chinese patients with advanced non-small cell lung cancer.
Chinese medical journal - 1 Mar 2011
Qin Ling, Zhong Wei, Zhang Li, Li Long-yun, Wang Meng-zhao
Abstract excerpt
BACKGROUND: Epidermal growth factor receptor (EGFR) mutations can predict tumor response to tyrosine kinase inhibitors (TKIs). Detecting EGFR mutations in plasma DNA samples in patients with advanced non-small cell lung cancer is challenging and promising. We compared three methods for detecting plasma EGFR mutations, including direct DNA sequencing, denaturing high-performance liquid chromatography (DHPLC) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
